Astrazeneca Pharma India standalone net profit declines 2.44% in the March 2020 quarter

Sales rise 2.42% to Rs 194.90 crore

Net profit of Astrazeneca Pharma India declined 2.44% to Rs 9.58 crore in the quarter ended March 2020 as against Rs 9.82 crore during the previous quarter ended March 2019. Sales rose 2.42% to Rs 194.90 crore in the quarter ended March 2020 as against Rs 190.30 crore during the previous quarter ended March 2019.

For the full year,net profit rose 32.64% to Rs 72.21 crore in the year ended March 2020 as against Rs 54.44 crore during the previous year ended March 2019. Sales rose 14.21% to Rs 831.81 crore in the year ended March 2020 as against Rs 728.29 crore during the previous year ended March 2019.

ParticularsQuarter EndedYear EndedMar. 2020Mar. 2019% Var.Mar. 2020Mar. 2019% Var.Sales194.90190.30 2 831.81728.29 14 OPM %7.593.35 -14.519.79 - PBDT17.8912.38 45 132.5487.58 51 PBT13.358.47 58 113.9672.66 57 NP9.589.82 -2 72.2154.44 33

Powered by Capital Market - Live News